Phase 3 MAGNITUDE study: Results from second interim analysis of niraparib with abiraterone acetate and prednisone as first-line therapy in patients with metastatic castration-resistant prostate cancer with and without HRR gene alteration Meeting Abstract
| Authors: | Rathkopf, D. E.; Small, E.; Guckert, M.; Chi, K. N. |
| Abstract Title: | Phase 3 MAGNITUDE study: Results from second interim analysis of niraparib with abiraterone acetate and prednisone as first-line therapy in patients with metastatic castration-resistant prostate cancer with and without HRR gene alteration |
| Meeting Title: | 48th Annual Congress of the Oncology Nursing Society (ONS) |
| Journal Title: | Oncology Nursing Forum |
| Volume: | 50 |
| Issue: | 2 |
| Meeting Dates: | 2023 Apr 26-30 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0190-535X |
| Publisher: | Oncology Nursing Society (ONS) |
| Date Published: | 2023-03-01 |
| Start Page: | 7 |
| End Page: | 8 |
| Language: | English |
| ACCESSION: | WOS:000951988800474 |
| PROVIDER: | wos |
| DOI: | 10.1188/23.ONF.E3 |
| PUBMED: | 37677799 |
| Notes: | Meeting Abstract: P377 Found in PDF named "Late-Breaking Abstracts" -- Source: Wos |
